Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

GABA depression

Fused isoxazoles (631) were prepared as GABA analogs (75MI41604) and some exhibited CNS depression effects (74JAP(K)7480062) or were effective as minor tranquilizers, muscle relaxants and/or sleep inducers (76USP3966748, 79USP4163057). [Pg.128]

Barbiturates produce CNS depression, which ranges from sedation to general anesthesia. Action is through suppression of the mesencephalic reticular activating system. Barbiturates enhance GABA-induced inhibition the site of inhibition may be presynaptic in the spinal cord or postsynaptic in the cortical... [Pg.139]

The mu, delta and kappa opioid receptors are coupled to G° and G proteins and the inhibitory actions of the opioids occur from the closing of calcium channels (in the case of the K receptor) and the opening of potassium channels (for /i, d and ORL-1). These actions result in either reductions in transmitter release or depression of neuronal excitability depending on the pre- or postsynaptic location of the receptors. Excitatory effects can also occur via indirect mechanisms such as disinhibition, which have been reported in the substantia gelatinosa and the hippocampus. Flere, the activation of opioid receptors on GABA neurons results in removal of GABA-mediated inhibition and so leads to facilitation. [Pg.258]

Intracellular steroid receptors, which alter gene expression, exist for corticosteroids, oestrogens and progesterone in the brain, as in the periphery but they cannot account for the relatively rapid depression of CNS function induced by some steroids. This was explained when Harrison and Simmonds (1984) discovered that alphaxalone (the steroid anaesthetic) potentiated the duration of GABA-induced currents at the GABAa receptor in slices of rat cuneate nucleus just like the barbiturates (Fig. 13.6). Of the... [Pg.275]

Figure 15.9 Peptide modulation of striatal input to the globus pollidus. Enkephalin released from axon terminals of neurons of the indirect pathway (see Fig. 15.2 for details) is thought to inhibit GABA release from the same terminals so that feedback (auto) inhibition is reduced. This will free the neurons to inhibit the subthalamic nucleus (SThN) and its drive to GPint and SNr which in turn will have less inhibitory effect on cortico-thalamic traffic and possibly reduce akinesia. Dynorphin released from terminals of neurons of the direct pathway may also reduce glutamate release and excitation in the internal globus pallidus and further depress its inhibition of the cortico-thalamic pathway. High concentrations of these peptides may, however, result in dyskinesias. (See Henry and Brotchie 1996 and Maneuf et al. 1995)... Figure 15.9 Peptide modulation of striatal input to the globus pollidus. Enkephalin released from axon terminals of neurons of the indirect pathway (see Fig. 15.2 for details) is thought to inhibit GABA release from the same terminals so that feedback (auto) inhibition is reduced. This will free the neurons to inhibit the subthalamic nucleus (SThN) and its drive to GPint and SNr which in turn will have less inhibitory effect on cortico-thalamic traffic and possibly reduce akinesia. Dynorphin released from terminals of neurons of the direct pathway may also reduce glutamate release and excitation in the internal globus pallidus and further depress its inhibition of the cortico-thalamic pathway. High concentrations of these peptides may, however, result in dyskinesias. (See Henry and Brotchie 1996 and Maneuf et al. 1995)...
Coupland, N, Glue, P and Nutt, DJ (1992) Challenge tests assessment of the noradrenergic and GABA systems in depression and anxiety disorders. Molec. Aspects Med. 13 221-247. [Pg.421]

Setting aside the general anaesthetics, which do not directly modify the function of any particular neurotransmitter, all the drugs that are used to induce sleep, i.e. the hypnotics , augment the function of GABA and so directly depress neuronal function and probably facilitate cortico-thalamic synchrony. Most of them are benzodiazepines... [Pg.495]

Gao, X. B. van den Pol, A. N. (2001). Melanin concentrating hormone depresses synaptic activity of glutamate and GABA neurons from rat lateral hypothalamus./. Physiol. 533, 237-52. [Pg.101]

There is evidence for the contribution of serotonin dysfunction to mania, and in the mechanism of action of mood stabilizers [19], however, specific data on the serotonergic system and mania are fewer and variable. Moreover, altered functioning of other neurotransmitters in mania such as norepinephrine, dopamine, acetylcholine, and GABA, and their interaction with serotonin, are also likely to be involved in the pathogenesis of mood disorders. Differences in these neurotransmitter systems possibly underlie differences in the pathogenesis of depressive and manic episodes. [Pg.891]

Endocannabinoids serve as retrograde messengers. They are released by postsynaptic neurons and act on presynaptic CB1 receptors on neighboring nerve terminals. Retrograde signaling by endocannabinoids is essential for many forms of synaptic plasticity that are initiated by postsynaptic depolarization and increased postsynaptic intracellular Ca2+> but expressed as a presynaptic decrease in the probability of transmitter release. Examples include some forms of long-term depression (LTD see Ch. 53) at GABA... [Pg.920]


See other pages where GABA depression is mentioned: [Pg.32]    [Pg.32]    [Pg.530]    [Pg.535]    [Pg.548]    [Pg.409]    [Pg.218]    [Pg.223]    [Pg.228]    [Pg.228]    [Pg.233]    [Pg.192]    [Pg.534]    [Pg.150]    [Pg.220]    [Pg.244]    [Pg.317]    [Pg.343]    [Pg.348]    [Pg.403]    [Pg.466]    [Pg.497]    [Pg.239]    [Pg.475]    [Pg.571]    [Pg.757]    [Pg.160]    [Pg.42]    [Pg.224]    [Pg.6]    [Pg.119]    [Pg.121]    [Pg.183]    [Pg.291]    [Pg.296]    [Pg.889]    [Pg.892]    [Pg.893]    [Pg.903]    [Pg.35]   
See also in sourсe #XX -- [ Pg.36 , Pg.162 , Pg.184 ]




SEARCH



Depression GABA, role

GABA

GABA and Depression

© 2024 chempedia.info